Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To evaluate efficacy of Finalgon® cream (1.08% Nicoboxil/ 0.17% Nonivamide) versus placebo in
patients with acute low back pain. To investigate the safety and tolerability of repeated use
of Finalgon® cream (1.08% Nicoboxil/ 0.17% Nonivamide).